검색어: minimising (덴마크어 - 독일어)

minimising the risk of transmitting animal spongiform encephalopathy agents via medicinal products.
m inimising the risk of transmitting animal spongiform encephalopathy agents via medicinal products.

minimising the risk of transmitting animal spongiform encephalopathy agents via human and veterinary medicinal products
minimising the risk of transmitting animal spongiform encephalopathy agents via human and veterinary medicinal products

note for guidance on minimising the risk of transmitting animal spongiform encephalopathy agents via human and veterinary medicinal products
note for guidance on minimising the risk of transmitting animal spongiform encephalopathy agents via human and veterinary medicinal products

[5] ‘minimising administrative costs imposed by legislation’, sec(2005)175.
[5] „minimierung der durch rechtsvorschriften bedingten verwaltungskosten”, sek(2005) 175.

this project will demonstrate new technology for minimising emission vocs by means of an innovative process for caption, conduction and elimination by catalytic oxidation.
dieses projekt dient der demonstration neuer technologie für die minimierung von voc-emissionen mittels eines innovativen verfahrens für das auffangen, weiterleiten und beseitigen flüchtiger organischer verbindungen durch katalytische oxidation.

titel på dokumentet note for guidance on the use of bovine serum in the manufacture of human biological medicinal products points to consider on quality aspects of medicinal products containing active substances produced by stable transgene expression in higher plants revision of note for guidance on minimising the risks of tse transmission via medicinal products points to consider on the development of live attenuated influenza vaccines
titel des dokuments note for guidance on the use of bovine serum in the manufacture of human biological medicinal products points to consider on quality aspects of medicinal products containing active substances produced by stable transgene expression in higher plants revision of note for guidance on minimising the risks of tse transmission via medicinal products points to consider on the development of live attenuated influenza vaccines

titel på dokumentet revision of note for guidance on minimising the risks of tse transmission via medicinal products cpmp recommendations on vcjd and plasma derived medicinal products – cpmp recommendations on transmissible agents and urinary derived medicinal products note for guidance on the use of bovine serum used in the manufacture of human biological medicinal products note for guidance on the production and quality control of animal immunoglobins and immunosera for human use cell culture inactivated influenza vaccines – annex to note for guidance on harmonisation of requirements for influenza vaccines eu recommendations for the influenza vaccine composition for the season 2002/ 2003 plasma master file:
titel des dokuments revision of note for guidance on minimising the risks of tse transmission via medicinal products cpmp recommendations on vcjd and plasma derived medicinal products – cpmp recommendations on transmissible agents and urinary derived medicinal products note for guidance on the use of bovine serum used in the manufacture of human biological medicinal products note for guidance on the production and quality control of animal immunoglobins and immunosera for human use cell culture inactivated influenza vaccines – annex to note for guidance on harmonisation of requirements for influenza vaccines eu recommendations for the influenza vaccine composition for the season 2002/2003 plasma master file: